Hematology Board Review 17+

Name: Hematology Board Review
Author: Springer Publishing Company

Springer Publishing Company

- Percuma
- Menawarkan Pembelian In-App

Penerangan

Pass your Hematology Boards with 200 exam-style questions, rationales and detailed progress!

Brought to you by Springer Publishing, this app features 200 board-style questions with answers, detailed rationales, and references, along with an outline-based review of all topics covered in the exam blueprint. Hematology Board Review is your comprehensive solution to pass your boards.

Install the free version today and jump start your studying!

We have provided a limited free version of the content that you can try before deciding to upgrade. This version includes a limited amount of practice questions and basic progress metrics.

Get your best value by upgrading to the Premium Version with a one time, in-app purchase. The Premium Version includes:

- Includes 200 board-style questions and answers with rationales
- Provides key point summaries of each topic area for quick study and easy recall
- Thorough coverage of hematologic malignancies, blood disorders, transfusion medicine, hematopoietic cell transplantation, and standard treatment regimens
- Tables providing key data and information related to staging, treatment options, and disease classifications
- Includes free access to mobile app and website – track and sync your progress on up to three devices!

Hematology Board Review is the perfect on-the-go study solution to help you prepare for your exam. Get started for free!

© Springer Publishing

Please contact us if you have any questions, suggestions, or comments: medical@hltcorp.com or 319-246-5299.

13 Sep 2018

Versi 5.23.0

This version includes a few improvements to make your experience smoother.

Let us know what you think by emailing us at feedback@hltcorp.com or by leaving a 5-star review.

Pembangun, Springer Publishing Company, belum menyediakan butiran tentang amalan privasi dan pengendalian data mereka kepada Apple. Untuk maklumat lanjut, lihat dasar privasi pembangun.